Structural basis for Cas9 off-target activity
- PMID: 36306733
- PMCID: PMC10103147
- DOI: 10.1016/j.cell.2022.09.026
Structural basis for Cas9 off-target activity
Abstract
The target DNA specificity of the CRISPR-associated genome editor nuclease Cas9 is determined by complementarity to a 20-nucleotide segment in its guide RNA. However, Cas9 can bind and cleave partially complementary off-target sequences, which raises safety concerns for its use in clinical applications. Here, we report crystallographic structures of Cas9 bound to bona fide off-target substrates, revealing that off-target binding is enabled by a range of noncanonical base-pairing interactions within the guide:off-target heteroduplex. Off-target substrates containing single-nucleotide deletions relative to the guide RNA are accommodated by base skipping or multiple noncanonical base pairs rather than RNA bulge formation. Finally, PAM-distal mismatches result in duplex unpairing and induce a conformational change in the Cas9 REC lobe that perturbs its conformational activation. Together, these insights provide a structural rationale for the off-target activity of Cas9 and contribute to the improved rational design of guide RNAs and off-target prediction algorithms.
Keywords: CRISPR; Cas9; X-ray crystallography; base pairing; genome editing; guide RNA; mismatch; nuclease; off-target.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests P.D.D. is a current employee of Caribou Biosciences, Inc., and C.-H.L., M.J.I., and P.C. are former employees of Caribou Biosciences, Inc. M.J. is a cofounder of Caribou Biosciences, Inc. M.J., M.J.I., P.C., and P.D.D. are named inventors on patents and patent applications related to CRISPR-Cas technologies. SITE-Seq is a registered trademark of Caribou Biosciences, Inc.
Figures






Similar articles
-
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.Nat Commun. 2020 Aug 17;11(1):4132. doi: 10.1038/s41467-020-17952-5. Nat Commun. 2020. PMID: 32807781 Free PMC article.
-
Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.Proc Natl Acad Sci U S A. 2017 May 23;114(21):5443-5448. doi: 10.1073/pnas.1619926114. Epub 2017 May 8. Proc Natl Acad Sci U S A. 2017. PMID: 28484024 Free PMC article.
-
CRISPR-Cas9 bends and twists DNA to read its sequence.Nat Struct Mol Biol. 2022 Apr;29(4):395-402. doi: 10.1038/s41594-022-00756-0. Epub 2022 Apr 14. Nat Struct Mol Biol. 2022. PMID: 35422516 Free PMC article.
-
Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.Methods. 2017 May 15;121-122:3-8. doi: 10.1016/j.ymeth.2017.03.006. Epub 2017 Mar 24. Methods. 2017. PMID: 28344037 Review.
-
Optimization of genome editing through CRISPR-Cas9 engineering.Bioengineered. 2016 Apr;7(3):166-74. doi: 10.1080/21655979.2016.1189039. Bioengineered. 2016. PMID: 27340770 Free PMC article. Review.
Cited by
-
In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region.CRISPR J. 2023 Apr;6(2):127-139. doi: 10.1089/crispr.2022.0077. Epub 2023 Jan 13. CRISPR J. 2023. PMID: 36637878 Free PMC article.
-
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation.Front Immunol. 2024 Apr 8;15:1375177. doi: 10.3389/fimmu.2024.1375177. eCollection 2024. Front Immunol. 2024. PMID: 38650946 Free PMC article. Review.
-
Recent advances in genome engineering by CRISPR technology.BMB Rep. 2024 Jan;57(1):12-18. doi: 10.5483/BMBRep.2023-0157. BMB Rep. 2024. PMID: 38053294 Free PMC article. Review.
-
Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine.Front Pharmacol. 2025 Mar 25;16:1563198. doi: 10.3389/fphar.2025.1563198. eCollection 2025. Front Pharmacol. 2025. PMID: 40201690 Free PMC article. Review.
-
CRISPR-MFH: A Lightweight Hybrid Deep Learning Framework with Multi-Feature Encoding for Improved CRISPR-Cas9 Off-Target Prediction.Genes (Basel). 2025 Mar 28;16(4):387. doi: 10.3390/genes16040387. Genes (Basel). 2025. PMID: 40282347 Free PMC article.
References
-
- Anzalone AV, Koblan LW, and Liu DR (2020). Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38, 824–844. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous